| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Obstetrics and Gynecology (X.Z., A.N.M., K.A.M., Q.L., M.P.L.) and Molecular Pharmacology and Physiology (M.P.L.), University of South Florida College of Medicine, Tampa, Florida 33612
Address all correspondence and requests for reprints to: Mark P. McLean, Ph.D., University of South Florida, 12901 Bruce B. Downs Boulevard, MDC037, Tampa, Florida 33612. E-mail: mmclean{at}health.usf.edu.
The scavenger receptor class B isoforms (SR-B) type I and type II mediate the selective uptake of high-density lipoprotein cholesterol and promote reverse cholesterol transport, an important atherosclerosis protection mechanism, in the liver. Previously it was shown that the hepatic expression of SR-BI and SR-BII is regulated by estrogen. In the present study, we demonstrate that estrogen differentially regulates expression of the glycosylated and nonglycosylated forms of SR-BI and SR-BII in rat liver and hepatic cells. We report that estrogen mainly induces the down-regulation of glycosylated SR-BI and the up-regulation of nonglycosylated SR-BII. To study how estrogen regulates expression of the SR-B isoforms, we constructed a SR-B minigene containing minimal genomic sequences and were able to demonstrate that estrogen directly regulates the pre-mRNA alternative splicing of the exogenously expressed SR-B minigene in hepatic cells. Furthermore, we showed that the overexpression of splicing factors alternative splicing factor/splicing factor 2, Transformer (Tra)-2
, and Tra2β changes the splicing pattern of SR-B dramatically, whereas other splicing factors, such as heterogeneous nuclear ribonucleoprotein-G, SC-35, and arginine/serine-rich p40, had no effect. We also demonstrate that estrogen regulates Tra2β expression levels in liver cells. These studies suggest that estrogen may regulate SR-B isoform expression at both the RNA splicing and posttranslational modification levels and that, for alternative splicing regulation, estrogen may function by regulating the expression of the splicing factors alternative splicing factor/splicing factor 2, Tra2, and especially Tra2β.
This article has been cited by other articles:
 |
|
 |
|
  K. Takeo, T. Kawai, K. Nishida, K. Masuda, S. Teshima-Kondo, T. Tanahashi, and K. Rokutan Oxidative stress-induced alternative splicing of transformer 2{beta} (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells Am J Physiol Cell Physiol, August 1, 2009; 297(2): C330 - C338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Fenske, A. Yesilaltay, R. Pal, K. Daniels, C. Barker, V. Quinones, A. Rigotti, M. Krieger, and O. Kocher Normal Hepatic Cell Surface Localization of the High Density Lipoprotein Receptor, Scavenger Receptor Class B, Type I, Depends on All Four PDZ Domains of PDZK1 J. Biol. Chem., February 27, 2009; 284(9): 5797 - 5806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Fenske, A. Yesilaltay, R. Pal, K. Daniels, A. Rigotti, M. Krieger, and O. Kocher Overexpression of the PDZ1 Domain of PDZK1 Blocks the Activity of Hepatic Scavenger Receptor, Class B, Type I by Altering Its Abundance and Cellular Localization J. Biol. Chem., August 8, 2008; 283(32): 22097 - 22104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jones and J. S Owen How does interferon inhibit HCV cell entry? Gut, May 1, 2008; 57(5): 573 - 574. [Full Text] [PDF]
|
|
|
|
|
|
K Murao, H Imachi, X Yu, W M Cao, T Nishiuchi, K Chen, J Li, R A M Ahmed, N C W Wong, and T Ishida Interferon {alpha} decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes Gut, May 1, 2008; 57(5): 664 - 671. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
